Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nanosphere to Release Q1 Results, Hold Investor Call Tuesday, May 13; Schedules Annual Shareholder Meeting for Thursday, May 29

Abstract:
Nanosphere, Inc., (Nasdaq:NSPH), which develops, manufactures and markets advanced molecular diagnostics systems, will report its results for the first quarter of 2008 after the market closes on Tuesday, May 13, 2008. The company will also hold a live investor conference call and webcast at 5:00 P.M., Eastern Standard Time.

Nanosphere to Release Q1 Results, Hold Investor Call Tuesday, May 13; Schedules Annual Shareholder Meeting for Thursday, May 29

Northbrook, IL | Posted on April 23rd, 2008

The teleconference can be accessed by dialing 888-713-4209 (U.S./Canada) or 617-213-4863 (international), participant code 77860716. The call will also be broadcast live over the Internet and can be accessed by interested parties at the Investor Relations tab on the Nanosphere website: www.nanosphere.us.

Participants may pre-register for the call at: https://www.theconferencingservice.com/prereg/key.process?key=P6EYXGWQ8 . Pre-registrants will be issued a pin number to use when dialing into the live call, which will provide quick access to the conference by bypassing the operator upon connection. For interested individuals unable to join the call or webcast, a replay will be available through May 27, 2008, by dialing 888-286-8010 or for international calls 617-801-6888, pass code 17835853, or on the company's website.

Annual Meeting

Nanosphere also announced it will hold its first annual shareholders meeting as a public company, in downtown Chicago, at 9:00 A.M., Central Time, on Thursday, May 29. The meeting will take place at the Westin Michigan Avenue Chicago hotel, located at 909 North Michigan Avenue.

The agenda for the meeting will include:

-- Election of directors

-- Ratify the audit committee's selection of Deloitte & Touche LLP
as the company's independent auditors

-- Transact such other business as may properly come before
the annual meeting.

After completion of the annual meeting's formal agenda, William Moffitt, Nanosphere' President and Chief Executive Officer, will provide an overview discussion of the company's progress in 2007 and early 2008.

####

About Nanosphere, Inc.
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene(r) System for direct genomic and ultra-sensitive protein detection. This easy-to-use and cost-effective platform enables simple, low-cost and highly sensitive genomic and protein testing on a single platform. Nanosphere is based in Northbrook, IL.

For more information, please click here

Contacts:
Nanosphere, Inc.
Roger Moody, CFO
847-400-9021


The Torrenzano Group
Stuart Pearlman
212-681-1700, Ext. 124

Copyright © PrimeNewswire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Unconventional superconductor may be used to create quantum computers of the future: They have probably succeeded in creating a topological superconductor February 19th, 2018

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Announcements

Unconventional superconductor may be used to create quantum computers of the future: They have probably succeeded in creating a topological superconductor February 19th, 2018

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

Financial Reports

Arrowhead Pharmaceuticals to Webcast Fiscal 2018 First Quarter Results February 3rd, 2018

Nanometrics Announces Preliminary Results for the Third Quarter of 2017: Quarterly Results Impacted by Delays in Revenue Recognition on Multiple Systems into Japan October 12th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Third Quarter Results July 27th, 2017

Nanometrics to Announce Second Quarter Financial Results on August 1, 2017 July 14th, 2017

Events/Classes

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Leti’s Chief Scientist Presents Optimistic Vision for Neuromorphic Hardware and Ultra-Low-Power Microdevices for Edge Computing at ISSCC: Leti’s Chief Scientist Presents Optimistic Vision for Neuromorphic Hardware and Ultra-Low-Power Microdevices That Are Based on Novel Emerging February 13th, 2018

Leti Chief Scientist Barbara De Salvo Will Help Kick Off ISSCC 2018 with Opening-Day Keynote: In Addition, Leti Scientists Will Present and Demo New Technology for Piezoelectric Energy Harvesting February 8th, 2018

Leti Presents Optical-Equipment Curving Technology that Improves Performance, Cuts Costs: ‘Disruptive Approach’ for Imaging Applications Presented in Paper At Photonics West and Demonstrated in Leti’s Booth February 2nd, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project